Has Matthew Beal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $319,469 in general payments to Matthew Beal, MD across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Beal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Beal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Beal, MD

Adult Reconstructive Orthopaedic Surgery · Columbus, OHNPI 1346406956

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $206,861 of the $319,469 with a category attached, or 64.8%. Medacta USA, Inc. accounts for 99.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $81,267 and has fallen 98.7% since, to $1,046 in 2025.

$319,469in general payments, 2019–2025

Across 144 payments — averaging $2218.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$317K
Solventum Corporation$600
Stryker$486
Think Surgical, Inc.$326
Zimmer Biomet$147
Smith+Nephew$114
plus $401 from 11 others

$2,252in research payments, 2019–2025

Across 1 payment — averaging $2251.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medacta USA, Inc.$2K

What the payments were for

Royalty or licence$206,86165%
Consulting fees$86,17527%
Speaking & faculty fees$9,6003%
Travel & lodging$11,8304%
Food & beverage$5,0032%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	113	$317,395
Solventum Corporation	1	$600
Stryker	4	$486
Think Surgical, Inc.	4	$326
Zimmer Biomet	2	$147
Smith+Nephew	1	$114
Onkos Surgical, Inc.	2	$100
Ferring Pharmaceuticals Inc.	7	$97
Johnson & Johnson	2	$46
Dynasplint Systems Inc.	1	$28
Relievant Medsystems, Inc.	1	$25
Biocomposites Inc	1	$20
Lima USA, Inc.	1	$19
Pacira Therapeutics, Inc.	1	$17
Amgen	1	$17
Orthofix Medical, Inc.	1	$17
Endo Pharmaceuticals Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$319,469 in reported general payments places this provider in the 85th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$155,600

Medicare patients

313

Services billed

711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	19	$22

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Columbus

Ray WasielewskiColumbus$9.6M
Jeffrey ReevesColumbus$46K
Nicholas KolodychukColumbus$26K
Robert FadaColumbus$214
Adolph LombardiNew Albany$14.7M
Viktor KrebsCleveland$7.5M
Keith BerendNew Albany$4.6M
Nicolas PiuzziCleveland$1.2M
Michael BloomfieldCleveland$321K
Jason HurstNew Albany$255K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →